Drug Abuse Advisory Committee
Executive Summary
Committee will consider abuse liability assessment and related issues for Kabi Pharmacia's nicotine nasal spray for smoking cessation (NDA 20-385) on Aug. 1. On Aug. 2, committee will discuss "issues related to nicotine and smoking." On Aug. 3, the committee will review R. W. Johnson's Ultram (tramadol) oral analgesic tablets for the treatment of pain. The meeting begins at 9 a.m. all three days at the Holiday Inn in Silver Spring, Md